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SESSION 1 
ISIS-4: RANDOMISED TRIAL OF ORAL CAPTOPRIL, 
ISOSORBIDE MONONITRATE AND OF INTRAVENOUS 
MAGNESIUM IN 58,000 PATIENTS WITH SUSPECTED 
ACUTE MYOCARDIAL INFARCTION 
D. O'Callaghno, J. H, Horgun on behalf of the ISIS-4 
Collaborative Group 
Beaumont Hospital, Dublin. 
58,000 patients were raodoraised in ISIS-4 from over 1000 
hospitals in 30 countries between July 1991 and 31 August 1993. 
Patients were eligible if they presented within 24 hours of sus- 
pected acute myocardial infarction with no clear indications for, 
or contraindications to, the study treatments (although planned 
use of a few days of intravenous or oral nitrates was permitted). 
About 40% were within 6 hours of pain onset. 75% had ST 
elevation, 25% were aged 70% 15% had heart failure, and 2% had 
systolic blood pressure < 100 ramHg 
Patients were randomly allocated in a 2 x 2 x 2 factorial design 
between one month of oral captopril (6.25 mg initial dose, 12.5 
rag 2 hours later, 25 mg 10-12 hours later and then 50 mg twice 
daily) versus placebo, one month of oral controlled-release 
isosorbide mouonitrate (lmdur: 30 mg initial dose, 30 mg 10-12 
hours later and then 60 nag each morning) versus placebo, and 
24 hours of intravenous magnesium sulphate (8 raraol initial bolus 
over 15 minutes followed by 72 mmcl)'versus open control. About 
75% received fibrinolytic and almost all antiplatelet therapy. 
The main comparisons are to be of 5-week and longer-term 
mortality amongst all those allocated each active therapy versus 
all those allocated the corresponding control. Principal subsidiary 
comparisons involve subdivisun by planned nitrate at entry and 
by the other randomly allocated treatments. Mode of death and 
major morbidity results will also be considered. 
REFERRAL FOR CORONARY ANG1OGRAPHY AFTER 
AN EXERCISE ECG: DECISION ANALYSIS COMPARED 
WITH AN INDIVIDUAL CLINICIAN, 
J. Kellett, *J. Graham. 
General Hospital, Nenagh, Co. Tipperary. 
*West Memorial Regional Hospital, Comer Brook, 
Newfoundland, Canada. 
The decisions by a single cardiologist as to which of 308 
consecutive patients to refer for angiography after treadmill 
testing were compared with their life expectancy gains from 
bypass urgery predicted by decision analysis. Neither patient age 
nor gender influenced the decision to perform angiography. The 
94 patients ent for angiograms exercised for a significantly 
shorter time (p < 0.001 ), had more ST deviation (p < 0.001 ), more 
angina (p < 0.002) and were more likely to have had a prior 
myocardial infarction (p < 0.001) than the 214 patients not 
referred. The mean life expectancy gain predicted from bypass 
surgery was also greater (p < 0.001) in those referred (2.9 + 1.7 
QALYs) than in those not referred for angiography (I.0 + 1,7 
QALYs). However, 1~.3 patients not referred were predicted to 
gain up to 5.7 QALYs from bypass surgery. Consequently the 
overall predicted life expectancy gain from the cardiologist's 
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intuitive decisions was only 0. I + 2.5 QALYs per patient. Had 
the referral decision been solely directed by decision analysis the 
overall gain per patient would have been 1.9 4- 1.6 QALYs, and 
135 extra patients (229 in total) would have been sent for 
angiography. Use of decision analysis, therefore might help make 
referral for angiography more efficient and consistent. 
HIGH INCIDENCE OF OESOPHAGEAL 
ABNORMALITIES DETECTED IN PATIENTS WITH 
TREATED CORONARY ARTERY DISEASE USING 24HR 
AMBULATORY MANOMETRY AND pH STUDIES 
B. Deb, M. T. P. Caldwell, P. O'CaUaghan, P. L Byroe, T. P. 
J. Hennessy, P. Crean, M. Walsh, G. Gearty. 
Departments of Surgery and Cardiology, St. James's Hospital, 
Dublin 8. 
Persistent chest pain with normal cardiac investigations is not 
uncommon following treatment of coronary artery disease. 
Oesophageal problems are often suspected but to date evaluation 
has proved difficult. Eight patients who had previously under- 
gone successful coronary artery bypass grafting or coronary 
angioplasty underwent 24hr ambulatory manoraetry, pH and ECG 
monitoring. Symptoms were correlated with the parameters meas- 
ured. 
Results: Six of 8 patients had pathological cid reflux and one 
had nutcracker oesophagus. One had a aormal study. Seven of 
the 8 patients reported a total of 63 pain events during the study 
period. Fifty (79%) of these vents were reflux related and all 63 
(100%) had an associated motility abnormality. The patient who 
had a normal study had 6 episodes of pain, all of which were 
associated with acid reflux events even though is overall profile 
was within normal imits. 
These data suggest that oesophageal events are a frequent 
cause of pain in patients with IHD even when the 24hr profile 
is considered within normal limits. Twenty four hour studies 
increase the diagnostic yield. 
BLMCC EAST OF THE RIVER. MOBILE CORONARY 
CARE, MARKET FORCES, MINISTERS AND THE MEDIA 
D. McC. Boyle, L D, S. Higginson, K. Salathia. 
Coronary Care Unit, The Ulster, North Down and Ards 
Hospitals Trust, The Ulster Hospital, Dundonald. 
Recent changes in Mobile Coronary Care (MCC) caused 
patient anxiety and were described as Bizarre & Ludicrous in the 
press. In 1970 MCC was provided by a doctor and nurse team 
in a dedicated estate car. In 1991 we switched to a dedicated 
ambulance with a paramedic, doctor and nurse team. In 1993 it 
became clear that this service was unaffordable. We devised a 
format o maintain the philosophy of MCC but cheap enough to 
be supported by management. We report an audit of a taxi driven 
doctor and nurse system compared with previous ystems (50 
patient samples). Mean delay between patient call and MCC 
arrival was, 1. using estate car 13' 12", 0 delays >30', 2. using 
ambulance 16'30", 2% delays >30', 3. using taxi 16'36, 6% delays 
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>30'. Longer delays were related to distance travelled. Mean 
delay between hospital requesting taxi and taxi arrival at hospital 
(330 calls) was 2'34" with 4.2% of delays >6'. We believe that 
MCC must continue, but will need continuing modification to 
cope with changing challenges. 
EARLY DIAGNOSIS OF ACUTE MYOCARDIAL 
INFARCTION BY A BED-SIDE SEMI-QUANTITATIVE 
RAPITEX MYOGLOBIN KIT IN ACCIDENT & 
EMERGENCY DEPARTMENT 
R. Chandler, P. Shah, F. Lavin, K. Daly. 
Cardiology Department, University College Hospital, Ga/way. 
Early diagnosis of acute myocardial infarction (MI) will 
facilitate decision with regard to administration f thrumbolysis 
for maximum myocardial salvage. Bedside diagnostic kits may 
have advantage over standard laboratory analysis for rapid diag- 
nosis. In a previous trial, we have shown an advantage ofmyoglobin 
(Mgb) over other cardiac markers in the early hours of Ml. Hence, 
we compared sensitivity and specificity of bed-side semi-quan- 
titative latex agglutination (Rapitex) kit for Mgb, with that of 
standard laboratory analysis of creatinine phosphokinase (CPK) 
in Accident & Emergency Department (A&E). 
A total of 28 patients (20 males & 8 females), aged less than 
75 years (mean of 59.82 yrs), who presented to A&E with 
classical history of chest pain with onset less than 12 hours were 
studied. Venous blood samples were collected for both bed-side 
Rapitex Mgb kit and serum CPK in A&E dept. Further blood 
samples were collected for serum CPK at 12 hours, day I and day 
2. ECGs were done simultaneously. Of the 16 patients with 
positive Mgb on admission, 7 had normal CPK (<250 IU/I) and 
ECG, 4 had normal CPK and abnormal ECG, 2 had elevated CPK 
and normal ECG and 3 had elevated CPK and abnormal ECG. 
In the above positive Mgb group, 15 patients had developed ECG 
changes and high CPK suggestive of MI by day 2. There were 
12 patients with negative Mgb on admission; of them, 10 had 
normal CPK and ECG, 1 had normal CPK and ECG suggestive 
of acute MI, and the remaining one had elevated CPK with no 
ECG changes. In this negative Mgb group, only 1 patient showed 
evidence of myocardial infarction. Rapitex Mgb showed sensi- 
tivity, specificity and positive predictive value of 93.75%, 91.66% 
and 93.75% respectively, and CPK showed values of 31.25%, 
91.66% and 83.33% respectively . 
In summary, bed-side Rapitex kit for Mgb could be an useful 
tool for early diagnosis of acute MI in A&E department and aid 
decision making in administration of early thrombolysis. 
SESSION 2 
PEAK EJECTION FRACTION PRODUCED BY THE 
ARBUTAMINE PHARMACOLOGICAL STRESS TEST - A 
COMPARIS ON WITH CONVENTIONAL BICYCLE EXERCISE 
I. C. Steele, A. M. Nugent, S. R. Vallely, N: P. S. Campbell, 
D. P. Nicholls. 
Royal Victoria Hospital, Grosvenor Road, Belfast. 
Although most cardiovascular stress tests involve exercise this 
cannot be performed in all patients. We set out to evaluate anew 
pharmacological stress testing (PST) agent called arbutamine, a 
eatecholamine with predominantly B l agonist effects. It was used 
in conjunction with a computer controlled, closed loop, delivery 
system. We looked specifically at its effect on left and right 
I.J.M.$. 
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ventricular ejection fractions (LVEF and RVEF respectiely). Ten 
patients with proven coronary artery disease underwent erect 
incremental bicycle exercise test (ETF) and supine PST. LVEF 
and RVEF were measured at rest and at peak stress during both 
tests, using a high speed, digital multiwire camera nd Tantalum 
178. Results are shown: 
peak LVEF mean (range) peak LVEF mean (range) 
ETT 51.0 (25-70) 48.5 (35-61) 
PST 52.8 (36-71) 52.7 (38-78) 
There was a significant correlation between the two tests for 
peak LVEF (r = 0.72, p = 0.02), but no significant correlation for 
peak RVEF (r = 0.2, p > 0.5). We conclude that the arbutamine 
stress test produces imilar left ventrleular inotropie responses to 
bicycle exercise despite a change in patient position for the 
studies),but different right venricular esponses. 
IMPROVED EARLY POSTOPERATIVE CARDIAC 
FUNCTION ASSOCIATED WITH SYSTEMIC INHIBITION 
OF FREE RADICAL PRODUCTION 
J. G. Coghlan, W. D. Flitter, R. Daly, G. D. Wright, C. D. 
llsley, T. Slate 
Harefield Hospital and Brunel University, Middlesex, 
England. 
In this randomised, ouble blind trial the clinical, haemodynamic 
and biochemical effects of xanthine oxidase inhibition (XOI) in 
patients undergoing coronary artery bypass grafting were as- 
sessed. Low dose allopurinol pretreatment significantly reduced 
postoperative inotrope requirement (5/25 v's 13125; p 0.01) and 
increased the rate of peripheral rewarming (11.45:85 hrs v's 
14.4+1 hrs; p 0.02). Twenty patients (11 placebo) underwent 
invasive haemodynamic monitoring and intraoperative coronary 
sinus cannulation. Relative to the placebo group higher cardiac 
indices were recorded in the active treatment group from four 
hours postoperatively (F = 8.1; DF = 1,18; p 0.006). The net 
increase in products of lipid peroxidation was significantly less 
in the active treatment group (+94+40 nmol minutes/g albumin 
v's +219+40 nmol minutes/g albumin; p 0.02). Conclusion. The 
clinical and haemodynamic benefits of XO1 are preceded by a 
reduction of intraoperative lipid peroxidation. 
RESTENOSIS AFTER SUCCESSFUL PTCA IS 
INDEPENDENT OF VESSEL SIZE, QUANTITATIVE 
ANGIOGRAPHIC ANALYSIS IN 3072 PATIENTS 
D. P. Foley, R. Melkert, D. Keane, P. W. Serruys. 
Thoraxcentre, Erasmus University, Rotterdam, NL. 
New percutaneous transluminal coronary interventions are 
reported to be attended by somewhat lower restenosis rates (RR) 
than balloon angioplasty (PTCA). However, these interventions 
tend to be restricted to larger coronary vessels. The aim of this 
study was to objectively evaluate the effect of vessel size (VS) 
on "restenosis" (R), using both a continuous (loss during follow 
up, % diameter stenosis at follow up (% DSfup)) and categorical 
approach (% DSfup -> 50%), in a large homogenous patient group 
treated by PTCA. Angiography was performed under optimal 
conditions for quantitative analysis by the CMS system, using 
multiple projections, matched pre and post PTCA and at 6 months, 
on 3736 lesions, in 3072 patients, (92% angiographie follow up). 
Effect of VS on loss and % DSfup was evaluated by linear 
regression, and on the occurrence of R, by logistic regression. 
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Furthermore, loss, DSfup and RR were compared among 
lesion deciles (De, n=373) according to VS. 
~1 Dr 1~3 Ik4 lk5 De6 Ik7 I)c8 ~9 lk[0 'p' 
Vessel Size(tam) 1.74 2.05 2.23 2.38 2.50 2.64 2.79 2.95 3.17 3.66 0.00 
Luminal Joss (ram)0.29 0.28 0.27 0.28 0.32 0.29 0.29 0.35 0.34 0.28 0.47 
% DSatfup 47% 46% 45% 45% 46% 46% 46% 47% 48% 47% 0.64 
Resteno~isRate 31% 37% 31% 34% 35% 39% 37% 38% 39% 36% 0.20 
In regression analysis, VS did not influence luminal oss 
(p---0.47), diameter stenosis at fellow up (p=0.88), or occurrence 
of restenosis (p=0.77). Conclusion: by continuous or categorical 
approach, restenosis does not vary with vessel size. Reported 
benefits of other devices over PICA are thus unlikely to be due 
to less restenosis in larger vessels and may be attributed to 
intrinsic device specific advantages in provision of larger acute 
lumen. 
IS DECISION ANALYSIS THE BEST WAY TO COMPARE 
"ACCELERATED" tPA WITH STREPTOKINASE 
THERAPY? 
J. Kellett. 
General Hospital, Nenagh, Co. Tipperary. 
A decision analysis was constructed to model the chance 
events and outcomes likely to occur to a patient with a possible 
acute myocardial infarction giving aspirin, streptokinase, "accel- 
erated" tPA, or no treatment. The base case was a 60 year old man 
presenting four hours after the onset of symptoms with a definite 
acute myocardial infarction, having an anticipated 30 day mor- 
tality rate, without aspirin or thrembolytic treatment, of 16 per 
cent. Such a patient has a life expectancy at presentation of 10 
years and 316 days; treatment with aspirin alone will gain an extra 
226 days of quality adjusted life; treatment with aspii'in and 
stteptokinase will gain an extra 420 days. Treatment with aspirin 
and "accelerated" tPA will gain an extra 490 to 514 days, depend- 
ing on the efficacy of thrembolysis to reduce heart failure as- 
sumed. The threshold chance of stroke above which thrombolysis 
is no longer the preferred treatment is 6.0 per cent for streptokinase 
and 8.3 per cent for "accelerated" tPA. Varying the utility of 
stroke, and the chance and mortality of major bleed and anaphylaxis 
throughout their plausible ranges produces only trivial changes 
in expected outcomes. Provided acute infarction is certain and the 
chance of dying from infarction is 16 per cent, the cost of 
"accelerated" tPA therapy is IRs more per quality adjusted 
life year saved than treatment with streptokinase. 
LJ.M.S. 
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CompIel Medtlplr D~tiwa % Po~ Uncovered 
No Thrombosis (n=50) 12% 47% 14+12 25+13 14% 
Thrombosis (n=10) 40%* 50% 235:29 405:25# 60%# 
(*p=0.05, #p<0.01) 
Stent thrombosis was associated with complex lesion mor- 
phology, uncovered issection post-procedure and a greater e- 
sidual stanosis. An optimum angiographic result is of key impor- 
tance in reducing stent thrombosis following stenting in failed 
PTCA. 
SESSION 3 
DOES RESTENOSIS APIER CORONARY 
INTERVENTION VARY WITH THE DEVICE USED? 
D. P. Foley, R. Melkert, V. A. Umans, P. de Jaegere, 
P. W. Serruys. 
Thuraxcentre, Erasmus University, Rotterdam, NL. 
Angiographic results 6 months after successful coronary in- 
tervention may be evaluated according to the degree of luminal 
renarrowing (luminal oss) during follow up (Cup) or the residual 
lumen (minimal uminal diameter) at Cup (MLDfup). To deter- 
mine possible angiogrephic predictors of these results and the 
influence of the type of device used, multivariate linear egression 
techniques were applied to quantitative angiographic data ob- 
tained pro and post procedure and at Cup in 1560 patients with 
1787 lesions, treated by balloon angioplasty, directional 
atherectomy (DCA), Wallstant (WA) or Wiktor stent (Wl) im- 
plantation. Because of the wide range in vessel size (VS), meas- 
ured luminal changes occurring at intervention and during Cup 
were adjusted accordingly, to derive relative gain (RG, gain/VS) 
and relative loss (RL, Ioss/VS). Results: RL was independently 
determined by RG (p<.0001) and MLD pro (p<0.O01). Further- 
more, RG achieved by DCA independently predicted greater RL 
(p=0.007) and RG by Wallstent, predicted less RL (p=0.03), 
compared with the other devices. MLDfup was determined by 
MLD post (p<0.0001), but also by VS (p<0.0001) and was 
negatively associated with RG (p<0.001), but not by the device 
used. Conclusion: Luminal renarrowing appears predominantly 
determined by increase at intervention and is influenced by the 
device used, whereas, residual lumen at follow up depends on 
vessel size and post-procedural lumen, is negatively associated 
with relative gain and not influenced by the device. Thus, al- 
though the "restanosis process" appears to vary with the device, 
"late angiographic outcome" does not. 
THROMBOSIS FOLLOWING STENTING IN FAILED 
PTCA: FREQUENCY, CONSEQUENCES, AND 
PREDICTORS 
J. B. Foley, K. Sridhar, R. 1. G. Brown, I. M. Penn. 
Victoria Hospital, London, Ontario. Canada. 
One hundred and five Palmaz-Schatz stents were implanted 
in 60 patients with failed PTCA. Acute sterlt thrombosis (<24 
hours) occurred in 3 (5%) and subacute (24 hours-I month) in 7 
(11.7%). Stent thrombosis was associated with Q-wave MI in 3 
and non-Q-wave MI in 5. Shown are the frequency of complex 
morphology (ACC/AHA B2 or C), multiple stent implantation, 
dissection length (ram), stenusis post stenting and uncovered 
dissection post-procedure. 
IMMEDIATE AND MEDIUM-TERM RESULTS OF 500 
CONSECUTIVE PATIENTS UNDERGOING 
PERCUTANEOUS TRANSLUMINAL CORONARY 
ANGIOPLASTY (PTCA) AT A SINGLE INSTITUTION 
J. Galvio, M. Codd, A. Hennessy, S. Leavey, E. Keelan, 
C. McCarthy, D. Sugrue. 
Department of Clinical Cardiology, Mater Misericordiae 
Hospital, Dublin. 
Introduction: Although there is an abundance of data on 
procedural and immediate outcome following percutaneous 
transluminal coronary angioplasty (PICA), medium term results 
have received little attention. We now report clinical follow-up 
on 500 consecutive patients who underwent PICA at a single 
institution between June 1985 and October 1991. 
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Results: Mean patient age was 57 years and 71% were male. 
55% had had unstable angina, 37% had had a previous myocardial 
infarction and 5% had previous coronary bypass grafting (CABG). 
81% of patients had a single vessel dilated, 16% of patients had 
2 vessels dilated and 3% of patients had 3 vessels dilated. The 
number of lesions dilated was 1 in 72%, 2 in 19.2%, 3 in 7.2% 
and > 3 in 1.6%. Clinical follow-up was obtained in 99.6% of 
patients at 9-94 months (mean 35 months). At follow-up, 48% 
of patients had no or rare angina without further intervention. 
5.4% of the original 500 patients had died, 1% during or within 
24 hours of the procedure. 4% of patients had an MI, 2% during 
or within 24 hours of the procedure. 24% of patients underwent 
CABG by the time of follow-up, 1.8% within 24 hours of the 
procedure. 16% of patients had a repeat PTCA. 
Conclusion: During medium term follow-up after PTCA al- 
most half of the patients had no further symptoms or rare symp- 
toms only without additional intervention. Most of the remaining 
patients required repeat revaseularisation, more often with CABG 
than with a second PTCA. 
DIABETES MELLITUS INCREASES RESTENOSIS 
FOLLOWING BALLOON ANGIOPLASTY 
D. Keane, D, P, Foley, P. W. Serruys. 
Thoraxcenter, Erasmus University, Rotterdam, The 
Netherlands. 
Acute and long-term angiogtaphic outcome of PTCA in 179 
lesions in patients with diabetes mellitus (DM) was compared 
with that of 1891 lesions in patients without (N) diabetes mellitus 
who participated in multieentre stenosis prevention trials. As 
vessel size (RVD) was smaller in DM than in N, we therefore 
examined relative gain (RG) - the acute gain in MLD normalised 
for vessel size, and relative loss (RL) - the late loss inMLD 
normalised for vessel size, and net gain index (NGI) - the differ- 
ence between RG and RL. Percent diameter stenosis (% DS) in 
DM and N was similar pre and post PTCA but different at follow- 
up flu). The restenosis rate (defined as % DS>50%) in N was 30% 
and in DM 42% - tel. risk 1,4 (1.16-1.68). 
RVD MLDpre MLDpest MLDfu %l~fu RG RL NGI 
DM 2.53 0.98 1.73 1.31 50.2 0.30 0.18 0.12 
:s :[:0.36 :s :1:0.67 2:22.8 :s :s 2:0.25 
N 2.61 1.02 1.77 1.50 43.8 0.29 0.It 0.19 
:t:0.53 :s :s :s -I-18.6 -2"0.16 :~0.21 -2"0.22 
p 0.049 0.12 0.09 0.0002 0.0004 0.64 0.(3005 0.002 
Conclusion: Vessel size is smaller in DM than in N selected 
for PTCA. Despite an equivalent RG (injury), restanosis follow- 
ing PTCA in DM is greater than in N. 
PRIMARY VERSUS SECONDARY STENTING IN FAILED 
ANGIOPLASTY 
1. B. Foley, K, Sridhar, R. I. G. Brown, I. M. Pann. 
Victoria Hospital, London, Ontario, Canada. 
The safety and efficacy of immediate Palmaz-Schatz stenting 
(primary stenting) and prolonged inflation with a perfusion bal- 
loon (PB) followed by stent implantation if necessary (secondary 
stenting) for failed PTCA was determined in 46 patients (23 in 
each group) matched for angina status, vessel and reference vessel 
diameter. The duration of the maximum inflation achieved in the 
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PB group was 115:8 rain. Angiographic success (<50% stenosis 
and TIMI 3 flow) was achieved in 91% of the primary stent group 
and 39% of the PB alone group (p=0.001). Secondary stenting 
was successful in 8/12 with PB failure. Stent hrombosis occurred 
in 19% of all stented patients. Allowing for 1 repeat angioplasty 
for restenosis 82% of the stent group and 61% of the PB/second- 
ary stent group were free from angina or major complications at 
1 year, p=0.09. Primary stenting had a more favourable Iongterm 
outcome than PB/secondary-stenting. 
BALLOON ANGIOPLASTY OF NATIVE COARCTATION 
B. G. Craig, H. C. Mulholland. 
Clark Clinic, Royal Belfast Hospital for Sick Children, 
Belfast. 
Balloon angioplasty has become an accepted form of thera- 
peutic intervention i  recoarctation Of the aorta following previ- 
ous surgery. Balloon angioplasty for native coarctation is more 
controversial nd we report our early results with this procedure. 
Eight procedures Were performed in 7 children since January 
1991. The mean age was 6.3 yrs (range 1.5 yrs to 14.4 yrs). The 
mean peak-to-peak systolic gradient by manometry was 44 msHg 
(range 36 mmsHg to 56 mmsHg). This fell to a mean of 21 mmsHg 
(range 12 mmsHg to 28 mmsHg) following angioplasty. In one 
patient the angioplasty was successfully repeated 19 months 
fullowing the first procedure. There were no major complications. 
In particular no patient developed an aortic aneurysm or femoral 
arterial occlusion. Balloon angioplasty provides an alternative to
surgery for the relief of native coarctation. Some patients may 
require repeat procedures for an effective longer term result. 
SESSION 4 
DIFFERING PTCA MECHANISMS IN STABLE AND 
ACUTE CORONARY DISEASE: A STUDY WITH PRE- 
AND POST-PTCA INTRACORONARY ULTRASOUND. 
P. Kearocy, R. Ethel*, L. Koch, J. Ge*, G. GOrge*, J. Meyer. 
Mainz and Essen* University Clinics, Mainz and Essen, 
Germany. 
The wall viewing potential ofintracoronary ultrasound (ICUS) 
has unique advantages in demonstrating the mechanisms of 
angioplasty. We compared the mechanisms of PTCA in patients 
(pts) with stable and acute coronary disease (unstable angina nd 
acute myocardial infarction) using ple and post PTCA ICUS. 
Of 18 pts included in the study, 9 had stable angina (S) and 
9 acute coronary disease (A). 3.5F ICUS catheters attached to a 
Diasonics console were advanced over the lesion before and after 
PTCA and images of vessel sites, identified by simultaneously 
acquired cine recordings, were recorded on video for subsequent 
offline analysis. Lumen diameter and area, vessel and lesion area 
and % stenosis were quantified and morphological changes noted 
at the same site in the lesion pre and post PICA. 
Stretch Tear Dissection CLayer (?thrombus) 
Stable 67% 44%, 22% 0% 
Acute 67% 67% 33% 67% 
Z2 p value 1.0 0.34 0.60 0.003 
A demarcated homogenous inner layer of low echodensity (prob- 
able thrombus) was seen only in the pro PTCA images of A pts, 
which was absent post. A reduction in lesion crosssectional rea 
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occurred in pts with this layer but not in those without (p<0.05). 
All other mechanisms and quantitative changes were similar in 
those with S and A. 
Conclusions. ICUS demonstrates a layer of probable thrombus 
in the majority of patients with both myocardial infarction and 
unstable angina. We have shown for the first time a reduction of 
lesion cross-sectional rea after PTCA (consistent with displace- 
ment, compression or axial remodelling of thrombus), which is 
seen only in these patients. Previously described PTCA mecha- 
nisms (stretch, tear and dissection) were seen in both S and A pts. 
ELECTRICAL WAVEFORM AND ELECTRODE 
CONFIGURATION IN EP1CARDIAL AND 
ENDOCARDIAL ATRIAL DEFIBRILLATION 
D. Keane, D. Anderson, M. Marrinan, N. Sulke, R. Cooke, 
G. Jackson,'E. Sowton. 
Departments of Cardiology and Cardiac Surgery, Guy's 
Hospital, London, England. 
Paroxysmal trial fibrillation continues to present atherapeu- 
tic challenge. The development o fan implantable atrial defibrillator 
would offer significant advantages over current herapeutic ap- 
proaches. Patient tolerance of atrial shocks, however, would 
critically depend upon an optimal waveform and electrode con- 
figuration. 
We first compared the efficiency ofa biphasic and monophasic 
waveform in epicardial atrial defibrillation in 21 patients on 
cardiopulmonary b pass and then evaluated a right atrial - coro- 
nary sinus endocardial electrode configuration using the most 
efficient of the two waveforms in 16 patients undergoing elective 
cardioversion of chronic atrial fibrillation and flutter. During 
epicardial atrial defibrillation, the energy (Joules) required for 
80% success was 3.88 (0.59-7.07)J for the monophasic waveform 
and 0.58 (0.41-0.75)J for the biphasie waveform (p=0.04). Thus, 
the biphasic waveform was applied uring subsequent endocardial 
defibrillation which was successful in 15 of the 16 patients (4.2 
(+2.9) shocks): 8 of 9 patients with chronic atrial fibrillation 
cardioverted with 6.7 (• and of the 7 patients with atrial 
flutter direct conversion to sinus rhythm occurred in 2 (0.57 
(-+0.44).I), while in 5 the first shock (0.43(• induced atrial 
fibrillation and subsequent cardioversion required 3.4(• 
Atrial arrhythmias can be cardioverted efficiently with a biphasic 
waveform and a right atrial - coronary sinus eodocardial e ectrode 
system, indicating that an implantable atrial defibrillator would 
be a feasible treatment modality. 
AN ESOTHORACIC PACING SYSTEM FOR ATRIAL, 
VENTRICULAR AND AV SEQUENTIAL PACING AND 
ELECTROPHYS1OLOGICAL STUDIES 
D. J. McEneaney, J. Anderson, A. A. J. Adgey. 
Regional Medical Cardiology Centre, Royal Victoria 
Hospital, Grosvenor Road, Belfast BT12 6BA. 
A novel esothoracic (ESO) pacing system has been developed 
capable of atrial (A), ventricular (V) and AV sequential pacing 
and programmed stimulation. Under light sedation, the flexible 
polythene gastro esophageal electrode was swallowed or passed 
into the stomach. The electrode tip was then positioned in the 
gastric fundus using an internal pulley system. Four ring elec- 
trodes mounted proximally, now lying in the lower oesophagus, 
were used for A recording and pacing. V pacing used a cathodic 
point source on the electrode tip and a high impedance chest pad 
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(anode) placed medial to the apex. AV sequential pacing was 
attempted in45 patients with stable bradyarmythmias. A capture 
was achieved in 44/45 (98%) subjects and V and AV sequential 
capture in 41/45 (91%). ESO and external (transcutaneous, TC) 
pacing were compared in 18 patients. V capture was more fre- 
quent using ESO pacing (ESO 17/18 (94%), TC 6/18 (33%); 
p<0.001 ).Threshold current for V capture was significantly lower 
with ESO pacing. Emergency ESO V or A pacing was successful 
in the management of acute bradyarrhythmias (3 patients). 
Elactrophysiological studies were performed using ESO and 
endocardial (ENDO) programmed stimulation. Sinus node re- 
covery time (SNRT) and AV Wenckebach peint correlated closely: 
SNRT n=l 2, r=0,92, p<0.001; AV Wanckebach n=l 3, r=0.91, 
p<0.001. It was possble to induce and terminate ventricular 
taehyeardia (VT) using ESO programmed stimulation and pacing. 
The rate, morphology and haemodynamics of VT were similar 
using ESO and ENDO approaches. This ESO pacing system 
would be useful for emergency pacing. It enables a virtually 
complete lectrophysiological study to be performed without 
transvenous catheterisation r access to fiuorosscopy. 
EPICARDIAL STIMULATION IMPAIRS LOWER 
O6SOPHAGEAL SPHINCTER FUNCTION 
M. T. P. Caldwell, P. Marks, P. J. Byme, T. N. Walsh, T. P. 
J. Hennessy, P Crean. 
University Dept. of Surgery, St, James's Hospital, Dublin 8. 
There is a high incidence of oesophageal disease, particularly 
gastro-oesophageal r flux disease (GORD) in patients with treated 
coronary artery disease. The link between these two entities 
remains unclear. The effect of epicardial stimulation with friction 
and a nicotene soaked patch (200ug/ml) on lower oesophageal 
sphincter (LOS) function was studied in 7 adult mongrel dogs. 
LOS tone was recorded continuously throughout using a 
sphlnctometer. 
Results [mean(sere)] 
Control 1 Epicardial Control 2 Nieotenr 
friction patch 
LOS tone 
(sphinct0meter) 13.0(2.2) 6.2(1.7)* 12.8(2.2) 6.9(1.3)* 
Mean blood pressure 
(mmHg) 92(8) 72(7)* 89(7) 74(5)* 
* p < 0.03 vs control Wilcoxon signed rank test 
These data demonstrate hat LOS tone may be reduced by 
epicardial stimulation and the effect ofnicotene suggests that this 
change may be due to activation of C afferent vagal receptors in 
the myocardium of the left ventricle. This may explain the high 
incidence of GORD in patients with ischaemic heart disease. 
SESS ION 5 
RELATIONSHIP BETWEEN LIPID PROFILE AND THE 
PRESENCE AND EXTENT OF CORONARY ARTERY 
DISEASE 
J. Galvin, M. Codd, Leavey, D. Sugroe. 
Department of Clinical Cardiology, Mater Misericordiae 
Hospital, Dublin 7. 
Introduction: Serum cholesterol (chol), in particular LDL chol 
has been shown in numerous cross-sectional nd longitudinal 
studies to be an independent risk factor for coronary artery disease 
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(CAD). Apoproteln (ape) B- 100, A-I and more recently lipoprotein 
(a) [Lp(a)] have also been associated with an increased risk of 
CAD. It remains unclear however which measurement has the 
strongest predictive value for the presence or extent of CAD. To 
assess the relative predictive value of each of these risk factors 
for the presence or extent of CAD, we measured their levels and 
assessed cardiovascular risk factors in 157 consecutive subjects 
undergoing routine diagnostic coronary angiography. All coro- 
nary angiograms were read independently and a coronary angiogram 
scoring system applied. 
Results: Elevated ape B-100 (p=0.0001), chol (p=0.0002), 
LDL chol (p=0.0005), triglycerides (p=0.0017) and Lp(a) 
(p----0.0337) were all significantly associated with the presence of 
CAD in descending order of significance ina univariate analysis. 
Total ehol alone remained a significant predictor of the presence 
of CAD (p=0.0002) with multivariate analysis. Ape B- 100 alone 
was associated with the extent of CAD in beth a univariate 
(p=0.0103) and multivariate analysis (p=O.05). 
Conclusions: Although all parameters are significantly asso- 
ciated with the presence of CAD in this population, ape B-100 
and total chol possess the strongest association. A longitudinal 
study is needed to assess the predictive value of each test as a 
risk factor for the devlopment of atberesclerosis. 
EVALUATION OF RIGHT ATRIAL MASS LESIONS 
USING TRANSOESOPHAGEAL ECHOCARDIOGRAPHY 
J. J. Crowley, A. Kenny, P. Dardas, L. M. Shapiro. 
Regional Cardiac Unit, Papworth Hospital, Cambridge, 
England. 
The large number of anatomic variants in the right atrium 
makes differentiation f pathological lesions from normal struc- 
tures difficult by transthoracic eehocardiography (TTE). The 
improved image resolution of transoesophageal ehocardiography 
(TOE) allows better assessment of the size and characteristics of 
intracardi~ic masses. This study investigates the role of TOE in 
the evaluation of right atrial mass lesions. 
TOE was performed in 25 consecutive patients who had an 
equivocal echogenic structure seen in the right atrium by TTE. 
Echocardiographic studies were analysed independently by 2 
observers without previous knowledge of the clinical data for 
individual patients. 
A definitive diagnosis was made in 23 patients by TOE. 
Lesions identified included right atrial, thrombus (7 patients); 
right atrial myxoma (3 patients); atrial septal aneurysm (2 
patients); Chiari network (2 patients); and normal anatomic variant 
(9 patients). Lesion characteristics such as size, morphology and 
site of attachment to the atrial wall were clearly identified. We 
conclude that TOE is superior to TTE in thediagnosis of right 
atrial mass lesions and is useful in guiding appropriate therapy. 
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affinity state for fibdnogen and the appearance of new epitopes 
(ligandindueed binding sites or LIBS). Exposure of these sites 
may mediate platelet interactions with tissue adhesive molecules 
such as vitronectin, thromboxane (TX) A 2 generation and platelet 
aggregation. To explore whether this partial agonist effect altered 
platelet activity in rive, we examined the effects of integrelin, 
a GP llb/llla antagonist, in 6 patients with stable angina pectoris. 
Aspirin was withheld for 10 days prior to study. Integrelin 
markedly suppressed platelet aggregation to thrombin (88+5%, 
mean+SEM) and the thromboxane-mimetle 1346619 ( 3+6%). In 
all patients, integrelin i creased platelet binding of D3, a monoclonal 
antibody that identifies a LIBS on the l~-suhunit. 03 binding 
correlated strongly with increase in bleeding time for each patient 
(r=0.9). Urinary ll-dehydro-TXB2, an index of platelet activation 
in rive, was measured in 3 patients, and despite the increased D3 
binding, was unaltered by integrelin (145+25 vs 139+37 pg/mg 
creatinine at baseline). Thus, administration f a GP lib/Ilia 
antagonist invivo results in conformational changes of the receptor, 
but does not increase platelet activation. Furthermore these 
conformational changes may be important in mediating the in- 
crease in bleeding time seen with these agents. 
RESTENOSIS FOLLOWING BALLOON ANGIOPLASTY IS 
INDEPENDENT OF GENDER 
D. Keane, D. P. Foley, V. Umans, P. W. Serruys. 
The Thoraxcenter Erasmus University Rotterdam. 
Baseline measurements and acute and long-term results of 
PTCA, as assessed by quantitative coronary angiography, were 
compared in 407 lesions in females (F) and 1778 lesions in males 
(M) who participated in multicentre restenosis prevention trials 
in Europe & North America. While vessel size (RVD) and mini- 
mal luminal diameter (MLD) pre and post PTCA were slightly 
smaller in F than in M, MLD at follow-up (fu) was similar. To 
permit a direct comparison between vessels of different size, the 
concepts of relative gain (RG) and relative loss (RL) - the acute 
gain and late loss in MLD normalised for vessel size, and loss 
index (LI) - late loss normalised for acute gain were applied. The 
restenosis rate (% diameter stenosis (%DS) >50%) in F (27%) and 
M (31%) was not significantly different, 
RVD ~D pre MID ~t  MID r0 %DS [u IIG I~L LI 
F 2.53 0.97 1.69 1.44 44.5 0.29 O.lO 0.32 
:HI.51 :19.39 :H).37 :19.61} +90 :t9.17 :1i}.23 +1.82 
M 2.64 1.02 1.76 1.49 45.1 0.28 0.11 0.45 
t0.55 :19.39 :H).37 40.58 ~9 :t9.16 :t9.21 :td..52 
p 0.000l 0.02 0.0009 0.19 0.53 0.67 0.65 0.55 
Although RVD and MLD are slightly smaller in F than in M 
selected for PTCA, their RG and RL are equivalent. Thus acute 
anglographie outcome and subsequent restenos i following PTCA 
is independent of gender. 
PHARMACOLOGY OF A PLATELET GLYCOPROTEIN 
IIB/IIIA RECEPTOR ANTAGONIST IN PATIENTS WITH 
STABLE ANGINA PECTORIS 
N. Delanty, N. Moran, F. Catella, G. A. FitzGerald, 
D. J. Fitzgerald. 
Centre for Cardiovascular Science, University College Dublin 
and Mater Hospital, 41, Eccles Street. Dublin 7. 
Exposure of the platelet glycoprotein (GP) receptor llb/llla to 
RGD-containing peptides and other antagonists induces a high 
IMPAIRED PULMONARY GAS EXCHANGE IN STABLE 
CONGESTIVE HEART FAILURE DUE TO ALVEOLAR 
DYSFUNCTION 
D. Moore*, A. Westen, M. Hughes, B. Manrer*, J. Cleland. 
Cardiac Dept, St Vincent's Hospital, Dublin* and Royal 
Postgraduate Medical School, London, England. 
it has recently been recognised that arterial hypoxaemia may 
occur during exercise in congestive heart failure, although the 
mechanisms are uncertain. We have used the Roughton-Forster 
technique to measure the alveolar-capillary membrane conduct- 
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ance for carbon monoxide (Dm), and pulmonary capillary blood 
volume (VC) during single-breath estimations ofdiffusing capac- 
ity in 10 male patients with stable congestive heart failure of more 
than 6 months duration (LV ejection fraction 21.5 + 6.8%, age 
48 :t: 9yrs) on optimum medical therapy with diuretics and ACE 
inhihitors. Results were compared with 8 sex matched control 
subjects (44 + 12 yrs) without evidence of cardiac disease. None 
of the patients or controlswere smokers. 
DLCO DLCO Dill VC 
mmol/mi~KPa % predicted mmol/nUnJkPa nil 
CHF 5.69 + 1.41 57.5 -I- 10.6 7.6 • 2.6 45.1 :[:: 21.5 
Controls 9.80 :t: 2.03 96.0 4- 10.3 16.3 + 3.8 38.0 + 12.2 
p value <0.0001 <0.0001 <0.0001 0.42 
The substantial reduction in Dm in the patients indicates 
markedly reduced alveolarcapillary conductance and consequently 
increased resistance to pulmonary gas exchange. Allowing for 
increased pulmonary capillary transit ime in CHF, this suggests 
highly abnormal alveolar fuoction in the patient group. Despite 
severely impaired left vantricniar function, VC was not signifi- 
cantly increased, perhaps as a consequence of intensive diuretic 
therapy. These data confirm our previous reports of impaired 
diffusing capacity in congestive heart failure, and suggest that 
pulmonary gas exchange and hence dyspnoea nd functional 
capacity may be influenced by alveolar dysfunction in such 
patients. 
PSYCHOLOGICAL IMPACT OF PARTICIPATION IN THE 
CARDIAC TRANSPLANT GAMES 
H. M. McGee, J. H. Horgan. 
Department of Cardiology, Beaumont Hospital, Dublin. 
Despite preoperative deconditioning and lowered aerobic 
capacity for cardiac transplant patients, significant exercise ben- 
efits have been documented following bospital-based rehabilita- 
tion. Patient-led groups have also developed exercise-based events, 
e.g. the Cardiac Transplant Games. These may have significant 
psychosoeial, as well as physical, benefits but are also poterRial 
sources of stress. This study examined patients from the National 
Transplant Centre, Mater Hospital, wishing to participate in the 
1992 Cardiac Transplant Games in the Netherlands. Twenty 
patients (15m/5f) were assessed to determine medical suitability 
and prescribe training schedules. Psychological assessment was 
completed 9 weeks before (TI), the week before (T2) and 8 weeks 
after the Games (T3). This included physical symptoms, body 
image, anxiety, mood and health-related quality of life (QoL). 
One patient was advised not to participate, 5 withdrew (3 for 
health reasons), leaving 14 participants (13m/If), mean age 46.4 
(range 31-67) years. Results indicated significant effects for body 
image and physical symptoms; both improved from T1-T2, this 
was retained at T3. There was no change in anxiety, mood or 
health-related QoL over time. Thus participation in a sporting 
event by well-selected transplant patients was associated with no 
negative psychological effects but with decreased physical 
symptomatology and an enhanced body image. 
PERCUTANEOUS BALLOON PERICARDIOTOMY IN THE 
TREATMENT OF MALIGNANT PERICARDIAL EFFUSION 
B. Deb, P. Crean, I. Graham. 
Trinity Cardiology, St. James's and Adelaide Hospitals, Dublin 8. 
Recurrent pericardial effusion can be manifestation f meta- 
static malignant disease. Repeat catheter drainage or surgical 
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pericardial window are two common treatment modalities. 
Pereutancous balloon pericardectomy is an effective way of 
draining the effusion and preventing recurrence. This is a rela- 
tively new technique and is performed under local anaesthetic. 
We performed this procedure on a female paiient diagnosed as 
having metastatic malignant melanoma who presented with re- 
current pericardial effusion with clinical and ecboeardiographic 
features ofeardian tamponade. A window was created by causing 
a tear in the pericardium with a balloon dilating catheter (CRISTAL; 
25 mm diameter, 40 mm length). The patient tolerated the 
procedure well and remained asymptomatic from the cardiac 
point of view over the period of following 4 weeks. This 
procedure is reasonably safe, performed under local anaesthetic, 
and more importantly obviates the need for surgical procedure 
in terminally ill patients. 
ASSESSMENT OF BODY SURFACE MAPPING IN THE 
DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION 
C. Cnilen, G. Dempsey, G. Wright, L. Martin, G. MacKenzie, 
J. Anderson, J. Adgey. 
Cardiac Unit, Royal Victoria Hospital, Belfast, Northern Ireland. 
The additional spatial information provided by body surface 
maps may improve the early diagnosis of acute myocardial 
infarction (MI), facilitating the initiation of thrombolytic therapy 
to 'at risk' patients. 
The diagnostic power of a portable ECG mapping device, 
incorporating an easily applied, screen-printed harness of 64 
electrodes, was evaluated. QRS and ST-T iso-integral maps were 
compared in 83 controls and 61 patients (pts). Controls: 83(mean 
age 54yrs, 52 male), with no history of cardiac disease were 
selected randomly and mapped. Patients: 61 (mean age 64yrs, 40 
male) were mapped at first presentation ofchest pain suggestive 
of Ml (mean delay from onset of chest pain to map recording was 
208 rufus). Of these, 36 were mapped outside hospital. Fifty-two 
(85%) had definite MI changes on 12-lead ECG with subsequent 
confirmatory cardiac enzyme elevation. Nine (15%) presented 
with non-diagnostic ECG findings (5/9 had MI confirmed by 
subsequent significant increase in cardiac enzymes and 4/9 had 
the diagnosis of angina). 
Using the iso-integral measurements to compare MI pts with 
controls a multiple logistic regression analysis identified 8 sig- 
nificantly predictive sites (5 on QRS and 3 on ST-T). The result- 
ing discriminant function (DF) yielded a sensitivity of 90% (95% 
Ci = 82 - 99%) for the diagnosis of MI with a specificity of 96% 
(95% Cl = 92 - 100%). When the maps of the 9 pts with possible 
MI were assessed using the DF, 8 were classified as MI, including 
4/5 cases subsequently confirmed by significant enzyme leva- 
tion. 
These results suggest that discriminant function analysis of 
body surface maps leads to improvement in the earlier diagnosis 
of MI. 
CIGARETTE SMOKING CAUSES'INCREASED 
EXCRETION OF 8-EPI-PROSTAGLAND1N F2~, A FREE 
RADICAL DERIVED PROSTAGLANDIN 
N. Delanty, J, A, Lawson, D. ], Fitzgerald, G. A. FitzGerald. 
Centre for Cardiovascular Science, University College Dublin 
and Mater Hospital, 41 Eceles Street, Dublin 7. 
Cigarette smoke contains high concentrations of free radicals. 
These may he important in the pathogenesis of smoking-related 
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diseases, including coronary artery disease. 8- 
Epiprostaglandin(PG)F2~ is formed by free radical peroxidation 
of arachidonlc acid. It has marked biological activity, including 
platelet activation and vasoconstriction, effects that appear to be 
mediated through a thromboxane receptor. Formation of this 
metabolite may he a marker of free radical induced cellular injury. 
We have documented increased urinary levels of 8-epi-PGF2~ in
paracetamol and paraquot poisoning, conditions that are known 
to be associated with high levels ofoxidative stress. We measured 
(by gas chromatography-mass spectrometry) urinary 8-epi-PGF~ 
in 9 young healthy smokers of greater than 15 cigarettes per day 
and in 9 Young healthy non-smokers. Smokers had a 2.5 fold 
increase, with a mean (+ SD) excretion of 47 + 7 pgt'Ltmol 
creatinine in smokers vs 19 + 9 in non-smokers (p=0.05). There- 
fore, free radical induced injury occurs in subjects who smoke. 
8-Epi-PGF2= may play a role in the pathogenesis of unstable 
coronary syndromes and coronary artery spasm in smokers. As 
the formation of 8-epi-PGFz~ isnot dependent on eyclooxygenase 
activity, its production would be expected to be unaffected by 
aspirin therapy. 
EFFECTS OF VASODILATOR AGENTS ON 
CARDIOVASCULAR HAEMODYNAM1CS FOLLOWING 
INHIBITON OF NITRIC OXIDE SYNTHESIS 
N. A. Herity, J. D. Allen, B. Silke, A. A. J. Adgcy. 
Regional Medical Cardiology Centre, Royal Victoria Hospital 
and Departments of Physiology and Therapeutics and Clinical 
Pharmacology, Queen's University, Belfast. 
Excessive ndothelial production of nitric oxide (NO) medi- 
ates pathological vasodilatation in septic shock. Pharmacological 
inhibitors of NO synthesis have recently been used to treat this 
condition. The aim of this work was to investigate afall in cardiac 
output which has been observed to follow this treatment and to 
test whether it was reversible. Systemic (SVR) and pulmonary 
(PVR) vascular esistance and cardiac output (CO) were meas- 
ured in pentobarbitone anaesthetised pigs before and after admin- 
istration of an inhibitor of NO synthesis - NG-nitro-L-arginine 
methyl ester (LNAME 10 mg/kg i.v.) - alone (n=8) and followed 
by nicardipine (NIC 0.05 - 0.2 mg/kg i.v.: n=8), theophylline 
(THEO 7.5 - 10 mg/kg i.v.: n=8) or the cyclic GMF (cGMP) - 
selective phosphodiesterase inhibitor M&B 22948 (M&B I - 5 
mg/kg i.v.: n=8). A control group (n=8) received only normal 
saline. 
R~la', 
Pre-Rx L-NAME NIC Pre-Rx L-NAME THE0 Pre-Rx L-NAME M&B 
gVR 701::hS4 159I:ilgO* 507::E4tl" 1079"218 2369-~14' 1994~87"~ g34::O6 17834465* 1951~7 
PVIt 154::1t2 406::ifi2' 178::t:lgti" 222~4 527:~9' 316-~4t 1505:13 3 9+28* 203-a3~i" 
CO 7,1:~.5 5.8:::$.5* 8.6:~.41"~ 5.fdfl.3 4.1::E).3' 4.?::lfl.3t'~ 6:~5 5.0"~.4' 5.0"~.4 
[Mean :t: SEM, SVR and PVR expressed in dyne.see/era ~. CO in l/rain. Pre-Rx=Pre- 
treatment value. *P<0.01 vs control group, tP<O.05 vs<IrNAME alone, ttP<0.01 vs 
L-NAME alone] 
Systemic vaseconstriction following L-NAME was completely 
reversed by nicardipine and partly reversed by thcophylline with 
complete and partial restoration of CO respectively. M&B did not 
affect either variable possibly due to total inhibition of cGMP 
synthesis by L-NAME. All three agents partly reversed pulmo- 
nary vasoconstriction. The results suggest that the observed fall 
in cardiac output (L-NAME) is caused by increased afterload on 
the heart and is reversed by nicardipine and less potently by 
theophylline. These findings may prove valuable to those using 
inhibitors of NO synthesis to treat septic shock. 
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EFFECTS OF CANDOXATRIL, A NOVEL 
ENDOPEPTIDASE INHIBITOR, COMPARED TO 
FRUSEMIDE IN HEART FAILURE 
D. B. Northridge, N. C. Jackson, M. J. Metcalfe, 
H. J. Dargie. 
Western Infirmary, Glasgow and Pfizer Central Research, 
Sandwich. 
Atrial natduretic factor (ANF) has diuretic and vasodilator 
effects in chronic heart failure (CHF). ANF is degraded by neutral 
endopeptidase (NEP), and inhibitors of this enzyme may potentiate 
its beneficial effects in CHF. In this double-blind, randomised 
trial candoxatril (C), a NEP inhibitor, was compared to frusemide 
(F) in patients with mild CHF. Thirty male patients with left 
ventricular dysfunction (echocardiographic fractional shortening 
< 25%) and reduced exercise capacity were randomised to C 
200mg bid, C 400mg bid or F 20mg bid for 9 days of continuous 
therapy. The initial diuresis and 24 hour sodium excretion fol- 
lowing both doses of C was similar to F. Resting ANF levels 
increased 2- to 3-fold four hours following C 200rag and C 
400mg, and remained significantly elevated after 9 days. Con- 
versely, ANF levels fell by 50% following F. There was no rise 
in plasma renin (PRA) with C 200mg bid and C 400mg bid, 
compared with a 4-fold increase after F. At peak exercise, ANF 
levels were significantly higher and PRA significantly lower after 
C compared to F. Despite a comparable diuresis and natriuresis, 
candoxatril did not stimulate renin secretion, either at rest or on 
exercise, in marked contrast o frusemide. This novel diuretic 
merits further study in heart failure. 
MAGNETIC RESONANCE IMAGING PLANES FOR THE 
THREE-DIMENSIONAL ANATOMICAL 
CHARACTERISATION OF HUMAN CORONARY 
ARTERlES 
J. J. Crowley, A. R. C. Gates, C. L.-H Huang, A Gresham, 
T. A. Carpenter, L. D. Hall, L. M. Shapiro. 
Regional Cardiac Unit, Papworth Hospital and Dept. of 
Medicinal Chemistry, University of Cambridge, England. 
Magnetic resonance imaging (MRI) has the potential to pro- 
vide a noniuvasive means of obtaining 3 dimensional (3-D) 
images of coronary arteries. However, because of difficulty visu- 
alising vessels of such small size and mobility, images of only 
the proximal parts of the coronary arteries have been obtained in 
vivo. This study investigates a stratagy to allow the 3-D recon- 
struction of the coronary arteries in vitro. 
Seven cadaveric human hearts were pressure perfused with 
formalin to maintain coronary artery pateacy. A series of 
tomographic planes were devised based on the longitudinal and 
transverse axis of the heart which allowed imaging of the main 
coronary arteries in cross-section a d longitadinally. These images 
were then reconstructed into a 3-D image using commercial 
software. Using this imaging protocol 3-D reconstructions ofthe 
main coronary arteries were possible in all 7 cadaveric specimens. 
The left main, left anterior descending, left circumflex and right 
coronary artery were visualised for mean lengths of 10 mm (range 
6-13), 24 mm (range 2.0-3.5),30 mm (range 13-38) and 55 mm 
(range 31-82) respectively. 
This study has developed an imaging protocol which allows 
3-D reconstruction of the main coronary arteries in vitro. Such 
an approach may be potentially useful for the systematic clinical 
imaging of human coronary arteries in vivo. 
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DETECTION OF SHOCKABLE VENTRICULAR 
TACHYCARDIA BY IMPEDANCE CARDIOGRAPHY 
USING TWO ECGIDEFIBRILLATOR PADS 
P. W. Johnston, J. D. Allen, G. Dempsey, J. Jossinet, Z. 
Imam, J. Anderson, A. A. J. Adgey. 
Cardiac Unit, Royal Victoria Hospital, Belfast, 
Ventricular tachycardia (VT) may present with insignificant 
or significant (requiring DC shock) haemodynamic disturbance. 
To distinguish between them automatic external defibrillators use 
heart rate alone which is insufficient. The impedance cardiogram 
(ICG), as a non-invasive haemodynamie indicator, may improve 
the accuracy in detecting shockable VT. This study compared 
heart rate (>200/mini with the ICG recorded by a novel electrode 
configuration, using 2 ECG/defibrillator pads attached to the 
anterior chest wall between the 3rd and 7th intercostal spaces. In 
8 anaesthetised pigs the ICG and cardiac output (CO), measured 
by thermodilution were recorded simultaneously, firstly during 
ventricular pacing and then during VT. During pacing at 180, 240 
and 300/rain and following VT induced with ouabain, the peak 
ICG (dz/dt(max)) was averaged over 10 beats and the mean dz/ 
dt(max) correlated with CO by thermodilution. For the pacing 
and VT studies the correlation coefficients were r=0,40 
(y--0.036x+0.159, p<0.001, n= 174) and r=0.54 (y=0.051x§ 
p<0.001, n=127) respectively. During VT, CO<3L/min was 
considered shockable. Using the regression equation from the VT 
study CO<3L/min correlated with dz/dt(max)<0.23D./s. U ing 
heart rate alone (>200/mini shockable VT was detected with 29% 
(6/21) sensitivity and 28% (16/58) specificity and with dz/ 
dt(max)<0.23D./s alone, sensitivity was 62% (13121) (1><0.05) 
and specificity 83% (48/58) (p<0.01)..Thus the ICG recorded by 
a novel electrode configuration was superior to heart rate in 
determining shockable VT. 
A SIMPLIFIED APPROACH TO ABLATION OF THE 
SLOW PATHWAY LIMB OF ATR10-VENTRICULAR 
NODAL REENTRANT TACHYCARDIA 
R. Sheahan, D. Newman, P. Dorian. 
Division of Cardiology, St. Michael's Hospital, Toronto, 
Ontario, Canada. 
Selective ablation of the slow pathway with radiofrequeocy 
(RF) energy is an effective therapy of atrio-ventricular nodal 
reentrant tachycardia (AVNRT). Two methods can be used to 
achieve this result; an anatomical or an electrical guided ap- 
proach. We hypothesised that a simplified approach combining 
anatomic and eleetrogram characteristics would be safe and 
effective. This approach involved RF energy application to the 
inferior aspect of Koch's triangle, inferior and posterior to the His 
bundle deflection. At this site an A:V signal ratio of 1:3 was 
sought with fractionation of the A electcogram. A deliberate 
attempt not to selectively record slow pathway potentials was 
made. Absence of inducible tachycardia nd/or echo beats were 
used as markers of procedural success. Sixteen consecutive pa- 
tients were studied off drugs. Fifteen were female with a mean 
age 0f52.8 +4.2 years. Overall success was'achieved in15 (94%) 
patients. Two patients had symptom recurrence; both underwent 
repeat ablation (1 success, 1 failure). Two patients who had an 
initial failed ablation were successfully ablated at a later attempt. 
The mean ablation procedure time was 46.2 - -  11.8 rain. in 
duration. The RF applications were delivered on a mean of 7.7 
:t: 2.8 times per procedure. Junctional tachycardia occurred in 7 
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(35%) cases and six of whom had a successful outcome, None 
of the patients developed transient or permanent heart block or 
other complications. At follow up 2 months later all patients were 
asymptomatic and off all medications. 
In conclusion, asimplified approach to slow pathway ablation 
achieves ahigh success rate with few complications. It does not 
require a search for discrete potentials or extensive ablations 
often required with a strictly anatomical approach. 
CARDIOVASCULAR MORTALITY AND SOCIAL CLASS: 
EIGHT YEARS OF DATA FROM A CARDIAC REGISTER 
R. Meleady, K. S. Tan, C. O'Brien, I. H, Graham. 
Adelaide Hospital, Dublin 8. 
There is an inverse relationship between social class and 
cardiovascular mortality. The meehanisn of this relationship s
obscure. Using data from the Meath-Adelaide Cardiac Resister 
collected between 1985 and 1992, the best index of social class 
that showed this relationship was determined. The factors that 
may mediate this relationship were examined. 
Indices of social class examined were: medical card eligibility, 
occupation, education attainment levels and employment status. 
Of these, medical card eligibility was the best index of the inverse 
relationship between social class and mortality. 
Univariate analysis suggests that card holders were older, 
more likely to be female, to smoke and to have a complicated 
myocardial infarction. They are less likely to have a positive 
family history (table). 
Card holders Non-card holders 
(n=640) (n=436) 
In-hospital mortality % 9.7 21.7 
Mean age (SD) 60 (11) 70(10)* 
Female % 30 49* 
Positive family history % 53 40 
History oi" hypertension % 29 32 
Senlm cholesterol mmol/I (SD) 6.2 (l.3/ 5.9 (1 +4) 
Smokers % 78 65 
47 Complicated myocardial infarction % 37 
Infarct opography: 
Anterior septal/lateral infarct % 46 48 
Inferior/posterior infarct % 41 4t 
* =p<0.01 
However, multiple logistic regression analysis howed that he 
relationship between medical card eligibility and cardiovascular 
mortality was independent of the variables above. The relation- 
ship between social class and mortality do not appear to be 
mediated by the major cardiovascular risk factors and infarct site. 
MULTISITE INHIBITION OF THE PLATELET 
GLYCOPROTE[N lib/Ilia RESULTS IN GREATER 
SUPPRESSION OF PLATELET ADHESION TO 
FIBRINOGEN 
P. Madema, N. Moran, D. Fitzgerald. 
Centre for Cardiovascular Science, Mater Hospital and 
U.C.D., Dublin. 
Platelet aggregation is mediated by the interaction between 
platelet glycoprotein (GP) lib/Ilia and an Arg-GlyAsp, (RGD) 
sequence in fibrinogen. Compounds that mimic this sequence 
prevent platelet aggregation and are being assessed as antiplatelet 
therapy. However, other sites on GPlIb/IIla may also be involved. 
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Fibrinogen induces the expression of a novel epitope on the 
receptor that is recognised by a monoclanal antibody, D3. Block- 
ade of this site does not inhibit platelet aggregation, but abolishes 
clot retraction, a platelet-mediated response. We addressed the 
hypothesis that inhibition of multiple sites would be more effec- 
tive in preventing the platelet-fibfinogen adhesion by examining 
the interaction between anti-D3 and RO43-5054 and RO44-9883, 
two peptidomimetie antagonists of the RGD binding site. Adhe- 
sion was measured by incubation of washed human platelcts to 
fibrinognn coated on micrutitre plates and by scanning electron 
microscopy. Preincobation of platelets with RO-43 or RO-44 4.8 
nM induced a31 +8% (n=6) and 44_+6% (n=6) reduction in platelet 
binding. In contrast, anti-D3 0.3 Itg/2xl07 cells increased binding 
by 595:4% (n~3), suggesting that anti-D3 induced an active 
conformation ofthe receptor. The combination of anti-D3 and the 
RO compounds markedly inhibited binding of platelets (76-+5%, 
n=3 for RO43 and 84-+5%, n=3 for RO-44). In conclusion, the 
GPllb/llla exhibits multiple recognition sites for fibrinogan. 
Inhibition of one site alone may result in ianomplete inhibition 
of platelet activity in vivo. 
CARDIOPROTECTIVE LIPPOPROTEIN ALTERATION 
RESULTING FROM CONSUMPTION OF 
MONOUNSATURATE RICH BUTI'ER PRODUCED BY A 
MODIFIED BOVINE DIET 
D. M. O'Callaghan, S. M. Rafferty, M. C. Canton, 
B, F. Connolly, J. H. Horgan. 
Department of Cardiology, Beaumont Hospital, Dublin 9. 
Intake of increased monounsaturated (MFA) and polyunsatu- 
rated (PFA) fatty acids reduce LDL cholesterol but PFA may also 
reduce HDL cholesterol. By modifying the bovine diet a butter 
and cheese rich in MFA was produced. We compared the effects 
of dietary inclusion of MFA rich butter and cheese (diet B) to 
regular butter and cheese (diet A) and PFA rich butter and cheese 
(diet C) in 30 patients, (1 excluded) 23 male (mean age of 56.4 
years) with type lla hyperlipidaemia complying well to an AHA 
step 1 type diet. Using a double change over design and latin 
square, patients were randomised todiets A, B and C for 6 weeks 
each. The effects of these diets on serum cholesterol, triglyceddes, 
HDL, LDL, Cholesterol/HDL ratio, HDL2, HDL3 and LPa were 
observed. Otherwise diets and medications were unehangnd as 
observed by full dietary analysis. Adjusted means and standard 
errors were estimated using a linear model and a two tailed T test 
was used to compare means. MFA rich butter and cheese resulted 
in a significant elevation in HDL3 (0.98 to 1.11 mmoi.LP < 0.05) 
compared to baseline. Period C resulted in significant reductions 
in total HDL compared to period A and B (1.28 to 1.22 P < 0.05 
and 1.31 and 1.22 P < 0.05). Otherwise no significant changes 
were observed in serum lipids. This study suggests that inclusion 
of butter/cheese rich in monounsaturatas to the diet of mildly 
hyperlipidaemic patients ~sults in beneficial serum lipoprotein 
changes. 
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INADEQUATE MANAGEMENT OF HYPERLIPIDAEMIA 
FOLLOWING CORONARY BYPASS SURGERY 
D. B. Northridge, M. B. Buchaiter, A. Shandall, A, Reas. 
Departments of Cardiology, General Medicine and Medical 
Audit, University Hospital of Wales, Cardiff. 
Lipid lowering therapy is well established in secondary pre- 
vention, therefore a retrospective audit of the detection and 
management of hyperlipidaemia in 100 consecutive CABG pa- 
tients was carried out (mean age 61, range 44-78). No recorded 
lipid measurement was present in 17 eases, in a further 5 eases 
lipid levels had been measured but the results were not in the 
notes. The median (range) total cholesterol was 6.7 mmol/l (4.0- 
11.7) and the median triglyceride was 2.1 mmoYl (0,6-18.4). 
These results were included in the discharge summary in 37 cases 
(45%). Of the 41 patients with a serum cholesterol above the 
median, only 12 (27%) were referred to a dietician, and 8 (19%) 
were prescribed lipid lowering drugs. These interventions were 
no more frequent than in patients with cholesterol levels below 
the median [ 18 (42%) referred to dietician and 4 (10%) on drugs]. 
Of 16 patients with total cholesterol >8 mmol/l, only 5 were 
referred to a dietician and 4 were prescribed lipid lowering drugs. 
Although 83% of CABG patients had their lipids measured, 
only the minority with a high cholesterol were managed appro- 
priately. As a result of this audit local guidelines for the manage- 
ment of hyperlipidaemia in CABG patients have been imple- 
mented. 
COMPARISON OF IONIC AND NON-IONIC DYES IN 
CORONARY ANGIOGRAPHY: AN ASSESSMENT OF 
SAFETY AND COST 
B. Deh, L. Rajan, R. Sheehan, N. Ghaisas, P. O'Callaghan, 
P. Crean, M. Walsh, G. Geraty. 
Trinity Cardiology, St. James's Hospital, Dublin. 
In a randomised, ouble-blind study we compared the safety 
and cost of ionic (Urografin) vs. non-ionic (Niopam) contrast 
media in a select low risk group of patients undergoing routine 
daycase coronary angiography. The enrolment criteria for this 
study were patients who could perform an exercise test for at least 
6 minutes. Persons with known allergies, valvular heart disease, 
poor left ventricular function and/or asthma were excluded from 
the study. 1051295 (35.5%) patients were enrolled between 
March and July 1993. 24/55 (44.1%) patients in the Urografin 
group had transient minor symptoms during the procedure com- 
pared to 25/50 (50%) in the Niopam group (p-NS). 18/55 (32.3%) 
patients in the Urografin group had transient cardiovascular 
events i,e. hypotension, bradycardia, PVC's and T wave changes 
during the procedure compared to 9/50 (1g.7%) in the Niopam 
group (p-NS). None of the patients in either group had any sedous 
adverse vents or required any intervention medication. Niopam 
costs 6 times more than Urografin (57.30 vs. 19.50 for 100 mls). 
We concluded that Urografin can be safely used as a contrast 
media in a select low risk group of patients undergoing routine 
coronary angiography at a lower cost compared to Niopam. 
